H2020Individual fellowship2016–2017

AGEISM · Lifelong health, markers of ageing and senescence in a long-lived mammal.

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2016-01-01 → 2017-12-31
EU contribution
€183,455
Participants
1
Scheme
MSCA-IF-EF-ST

Lines connect the coordinator with its partners.

Results in brief

Lifelong health, markers of ageing and senescence in a long-lived mammal.

The ageing populations of most European countries involve major health, economic and social consequences. It is thus critical to understand the limitations of deferring the negative effects of ageing and the mechanisms involved in growing old. Improving the quality of life at old age in humans and predicting future changes in longevity patterns of societies might depend on our ability to develop indicators of how old we really are and how many healthy years we have ahead of us, and how those indicators depend on our health history across decades. Such efforts for reducing the impact of senescence in humans might be best investigated in equally long-lived animals. The aim of this fellowship was to improve our understanding of the factors that cause some individuals to age faster than others and influence ageing patterns, and to better grasp both the mechanisms of ageing and their consequences on senescence rates in long-lived species. To do so, I used innovative approaches by combining the study of senescence patterns to ageing mechanisms and how they interact with variations in lifelong health and stress status, and endocrinological measures of stress in Asian elephants. Overall, this Marie Curie Fellowship has resulted in the understanding of the variation in senescence patterns, its links to ageing rates and stress levels, but also to better understand ageing mechanisms and their consequences on senescence rates, in a long-lived species as humans. The substantial data and biological samples that have been collected through this project have contributed significantly to our understanding of the factors shaping senescence patterns in the Asian elephant, while paving the way for more in-depth molecular analyses. These analyses - which are currently underway - will help to better understand the underlying mechanisms of such patterns and to establish ageing markers as a potential health marker. My results will also contribute to provide new solutions to elephant management and healthcare.

Data: CORDIS, © European Union

Project objective

Given the ageing population in Europe, it is critical to understand the mechanisms involved in growing old. Our ability to reduce the impact of ageing in humans might be best studied in equally long-lived animals. Predicting future changes in longevity patterns might depend on our ability to develop indicators of how old we really are and how many healthy years we have ahead of us, and how those indicators depend on our health history across decades.My study will be the first linking lifelong disease history with physiological and molecular measures of ageing in a mammal as long-lived as humans. I will examine how different molecular ageing markers (telomere dynamics, oxidative stress and telomerase activity) interact with lifelong disease and reproductive history, and current endocrinological measures of stress and reproduction. This helps to better grasp both the mechanisms of ageing and their consequences on senescence rates, thus providing exceptional opportunities to identify the exact role of these markers in evolutionary processes and how they determine ageing rates and individual variation in senescence rates. It would also help us to establish which molecular markers best represent individual health history and to understand how health history can predict ageing rates. To do so, I will combine the world's most comprehensive demographic data on Asian elephants with bi-monthly health and disease records across life and with molecular ageing markers and hormonal correlates of stress and reproduction (N~240). I will determine: Q1.How does health decline with age? Q2.How does lifelong disease exposure and current health link with ageing markers? Q3.How does reproduction affect age-specific declines in health and current ageing markers? Q4.How does early stress affect age-specific declines in health and current ageing markers?

Original text from CORDIS.

Participants

Links

Data: CORDIS, © European Union